Since the late 1940s, when the first chemotherapies were introduced, advances in treatment for blood cancers have resulted in…
Articles by Marisa Horak, MS
A novel mRNA vaccine effectively triggered an antitumor immune response in a mouse model of pancreatic cancer, even completely…
September is Blood Cancer Awareness Month, and advocates around the world are joining together to shine a light on…
Ionis Pharmaceuticals’ experimental injection therapy sapablursen may ease symptoms of polycythemia vera (PV) and reduce the need for…
The U.S. Food and Drug Administration (FDA) has approved an oral drug for adults with pancreatic adenocarcinoma, the most common…
Safusidenib, an experimental oral treatment for people with gliomas carrying IDH1 gene mutations,…
Treating multiple myeloma with a Darzalex (daratumumab)-based combination may lead to a faster and longer-lasting response than a standard…
Adding Moleculin Biotech’s experimental chemotherapy annamycin to the approved chemotherapy cytarabine may be more effective than cytarabine alone at…
Two clinical trials evaluating cemsidomide — an oral therapy candidate from C4 Therapeutics (C4T) that aims to limit cancer…
Silexion Therapeutics has launched a Phase 2/3 clinical trial testing its experimental therapy SIL204 in combination with standard-of-care chemotherapy…